{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:34:23Z","timestamp":1790177663626,"version":"4.1.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570238"],"award-info":[{"award-number":["81570238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01193","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T13:53:24Z","timestamp":1596808404000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Basic Fibroblast Growth Factor Attenuates Injury in Myocardial Infarction by Enhancing Hypoxia-Inducible Factor-1 Alpha Accumulation"],"prefix":"10.3389","volume":"11","author":[{"given":"Zhiheng","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lushen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoping","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.114.302744","article-title":"Reperfusion Strategies in Acute Coronary Syndromes","volume":"114","author":"Bagai","year":"2014","journal-title":"Circ. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0008-6363(02)00708-3","article-title":"Biological Activities of Fibroblast Growth Factor-2 in the Adult Myocardium","volume":"57","author":"Detillieux","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1161\/CIR.0b013e318277d6a0","article-title":"2012 Accf\/Aha\/Acp\/Aats\/Pcna\/Scai\/Sts Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"60","author":"Fihn","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.tips.2015.06.004","article-title":"Novel Therapeutics in Myocardial Infarction: Targeting Microvascular Dysfunction and Reperfusion Injury","volume":"36","author":"Fordyce","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1161\/CIRCULATIONAHA.105.591792","article-title":"Cardiovascular Disease in the Developing World and Its Cost-Effective Management","volume":"112","author":"Gaziano","year":"2005","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0145-4145(08)04011-2","article-title":"Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006","volume":"2008","author":"Gersh","year":"2008","journal-title":"Yearbook Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1161\/01.CIR.0000105723.91637.1C","article-title":"Cardiac-Specific Overexpression of Fibroblast Growth Factor-2 Protects against Myocardial Dysfunction and Infarction in a Murine Model of Low-Flow Ischemia","volume":"108","author":"House","year":"2003","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1006\/jmcc.1994.1164","article-title":"Cloning and Expression of Fibroblast Growth Factor Receptor-1 Isoforms in the Mouse Heart: Evidence for Isoform Switching During Heart Development","volume":"26","author":"Jin","year":"1994","journal-title":"J. Mol. Cell Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"42919","DOI":"10.1074\/jbc.M206141200","article-title":"Activated Pp60c-Src Leads to Elevated Hypoxia-Inducible Factor (Hif)-1alpha Expression under Normoxia","volume":"277","author":"Karni","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature14582","article-title":"Hypoxia Fate Mapping Identifies Cycling Cardiomyocytes in the Adult Heart","volume":"523","author":"Kimura","year":"2015","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1161\/01.CIR.100.18.1865","article-title":"Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery: Results of a Phase I Randomized, Double-Blind, Placebo-Controlled Trial","volume":"100","author":"Laham","year":"1999","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1167\/iovs.17-23558","article-title":"Sirt1 Deletion Impairs Retinal Endothelial Cell Migration through Downregulation of Vegf-a\/Vegfr-2 and Mmp14","volume":"59","author":"Li","year":"2018","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"Hif-1alpha Pathway: Role, Regulation and Intervention for Cancer Therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B."},{"key":"B14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.yjmcc.2009.01.015","article-title":"Endothelium-Targeted Overexpression of Constitutively Active Fgf Receptor Induces Cardioprotection in Mice Myocardial Infarction","volume":"46","author":"Matsunaga","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart Disease and Stroke Statistics\u20132015 Update: A Report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra1112570","article-title":"A Tale of Coronary Artery Disease and Myocardial Infarction","volume":"366","author":"Nabel","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The Fibroblast Growth Factor Signaling Pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1101\/gad.266551.115","article-title":"Tibroblast Growth Factor Signaling in Skeletal Development and Disease","volume":"29","author":"Ornitz","year":"2015","journal-title":"Genes Dev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2004.05.067","article-title":"Fibroblast Growth Factor-1 Improves Cardiac Functional Recovery and Enhances Cell Survival after Ischemia and Reperfusion: A Fibroblast Growth Factor Receptor, Protein Kinase C, and Tyrosine Kinase-Dependent Mechanism","volume":"44","author":"Palmen","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0008-6363(00)00216-9","article-title":"Therapeutic Angiogenesis in Cardiology Using Protein Formulations","volume":"49","author":"Post","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature05602","article-title":"P53-Induced Inhibition of Hif-1 Causes Cardiac Dysfunction During Pressure Overload","volume":"446","author":"Sano","year":"2007","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1172\/JCI7315","article-title":"Fibroblast Growth Factor-2 Mediates Pressure-Induced Hypertrophic Response","volume":"104","author":"Schultz","year":"1999","journal-title":"J. Clin. Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0955-0674(00)00194-0","article-title":"Hif-1 and Mechanisms of Hypoxia Sensing","volume":"13","author":"Semenza","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"H1039","DOI":"10.1152\/ajpheart.2001.280.3.H1039","article-title":"Overexpression of Fgf-2 Increases Cardiac Myocyte Viability after Injury in Isolated Mouse Hearts","volume":"280","author":"Sheikh","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/hc0802.104407","article-title":"Pharmacological Treatment of Coronary Artery Disease with Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial","volume":"105","author":"Simons","year":"2002","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1152\/japplphysiol.00451.2002","article-title":"Targeted Disruption of the Fgf2 Gene Does Not Affect Vascular Growth in the Mouse Ischemic Hindlimb","volume":"93","author":"Sullivan","year":"2002","journal-title":"J. Appl. Physiol. (1985)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0074-7696(08)60149-7","article-title":"Fibroblast Growth Factors as Multifunctional Signaling Factors","volume":"185","author":"Szebenyi","year":"1998","journal-title":"Int. Rev. Cytol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28058","article-title":"Dexmedetomidine alleviates cerebral ischemia-reperfusion injury in rats via inhibition of hypoxia-inducible factor-1\u03b1 [published online ahead of print, 2018 Nov 19]","author":"Wang","year":"2018","journal-title":"J. Cell Biochem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01193\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T13:53:25Z","timestamp":1596808405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01193\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":28,"alternative-id":["10.3389\/fphar.2020.01193"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01193","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"article-number":"1193"}}